AAAAAA
Results:
1-18
|
Results: 18
Authors:
Culine, S
Ychou, M
Fabbro, M
Romieu, G
Cupissol, D
Citation: S. Culine et al., 5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas ofunknown primary site, ANTICANC R, 21(2B), 2001, pp. 1455-1457
Authors:
Ychou, M
Khemissa-Akouz, F
Kramer, A
Senesse, P
Grenier, J
Citation: M. Ychou et al., A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma, B CANCER, 88(10), 2001, pp. 1023-1027
Authors:
Ychou, M
Duffour, J
Kramar, A
Gourgou, S
Grenier, J
Citation: M. Ychou et al., Clinical significance and prognostic value of CA72-4 compared with CEA andCA19-9 in patients with gastric cancer, DIS MARKER, 16(3-4), 2000, pp. 105-110
Authors:
Ychou, M
Douillard, JY
Rougier, P
Adenis, A
Mousseau, M
Dufour, P
Wendling, JL
Burki, F
Mignard, D
Marty, M
Citation: M. Ychou et al., Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer - An open-label multicenterphase II study, AM J CL ONC, 23(2), 2000, pp. 143-148
Authors:
Topard, D
Hellier, I
Ychou, M
Guillot, B
Citation: D. Topard et al., Raltitrexed-induced skin reaction, ANN DER VEN, 127(12), 2000, pp. 1080-1082
Authors:
Ychou, M
Senesse, P
Quenet, F
Citation: M. Ychou et al., Update on gastroenterology, B CANCER, 87(6), 2000, pp. 455-461
Authors:
Joulia, JM
Pinguet, F
Ychou, M
Duffour, J
Astre, C
Bressolle, F
Citation: Jm. Joulia et al., Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid, EUR J CANC, 35(2), 1999, pp. 296-301
Authors:
Culine, S
Fabbro, M
Ychou, M
Romieu, G
Cupissol, D
Pujol, H
Citation: S. Culine et al., Chemotherapy in carcinomas of unknown primary site: A high-dose intensity policy, ANN ONCOL, 10(5), 1999, pp. 569-575
Authors:
Ducreux, M
Ychou, M
Seitz, JF
Bonnay, M
Bexon, A
Armand, JP
Mahjoubi, M
Mery-Mignard, D
Rougier, P
Citation: M. Ducreux et al., Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): A clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer, J CL ONCOL, 17(9), 1999, pp. 2901-2908
Authors:
Barbare, JC
Bedenne, L
Bouche, O
Cadiot, G
Calais, G
de Calan, L
Conroy, T
Ducreux, M
Etienne, PL
Elias, D
Faivre, J
Legoux, JL
Maingon, P
Mornex, F
Nordlinger, B
Ollier, JC
Peiffert, D
Pelletier, G
Rat, P
Rougier, P
Ruskone-Fourmestraux, A
Seitz, JF
Triboulet, JP
Trinchet, JC
Vetter, D
Ychou, M
Citation: Jc. Barbare et al., What can be done for patients with cancer of the digestive tract in 1999? Guidelines of the French Foundation of Digestive Tract Cancerology (2(nd) part), GASTRO CL B, 23(5), 1999, pp. 486-496
Authors:
Barbare, JC
Bedenne, L
Bouche, O
Cadiot, G
Calais, G
de Calan, L
Conroy, T
Ducreux, M
Etienne, PL
Elias, D
Faivre, J
Legoux, JL
Maingon, P
Mornex, F
Nordlinger, B
Ollier, JC
Peiffert, D
Pelletier, G
Rat, P
Rougier, P
Ruskone-Fourmestraux, A
Seitz, JF
Triboulet, JP
Trinchet, JC
Vetter, D
Ychou, M
Citation: Jc. Barbare et al., What can be done for patients with cancer of the digestive tract in 1999? Guidelines of the French Foundation of Digestive Tract Cancerology (1st part), GASTRO CL B, 23(4), 1999, pp. 502-512
Authors:
Kramar, A
Faraggi, D
Ychou, M
Reiser, B
Grenier, J
Citation: A. Kramar et al., The generalized ROC criterion for the evaluation of several tumor markers, REV EPIDEM, 47(4), 1999, pp. 376-383
Authors:
Bressolle, F
Joulia, JM
Pinguet, F
Ychou, M
Astre, C
Duffour, J
Gomeni, R
Citation: F. Bressolle et al., Circadian rhythm of 5-fluorouracil population pharmacokinetics in patientswith metastatic colorectal cancer, CANC CHEMOT, 44(4), 1999, pp. 295-302
Authors:
Ychou, M
Duffour, J
Pinguet, F
Kramar, A
Joulia, JM
Topart, D
Bressolle, F
Citation: M. Ychou et al., Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: A feasibility study in patients with advanced colorectal cancer, ANTICANC R, 19(3B), 1999, pp. 2229-2235
Authors:
Goineau, J
Ychou, M
Citation: J. Goineau et M. Ychou, Adjuvant hepatic intraarterial 5FU-folinic acid chemotherapy does not improve results after surgery for hepatic metastases from colorectal cancer, B CANCER, 86(6), 1999, pp. 519-520
Authors:
Goineau, J
Ychou, M
Citation: J. Goineau et M. Ychou, Active specific immunotherapy in adjuvant treatment of colon cancers, B CANCER, 86(4), 1999, pp. 335-336
Authors:
Leconte, A
Garambois, V
Ychou, M
Robert, B
Pourquier, D
Terskikh, A
Mach, JP
Pelegrin, A
Citation: A. Leconte et al., Involvement of circulating CEA in liver metastases from colorectal cancersre-examined in a new experimental model, BR J CANC, 80(9), 1999, pp. 1373-1379
Authors:
Ducreux, M
Gil-Delgado, M
Andre, T
Ychou, M
de Gramond, A
Khayat, D
Citation: M. Ducreux et al., Combination of irinotecan and other drugs in the treatment of colorectal metastatic cancer, B CANCER, 1998, pp. 43-46
Risultati:
1-18
|